603707 logo

Nanjing King-Friend Biochemical Pharmaceutical
603707

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥15.51B
EV
CN¥15.23B
Shares Outstanding
1.62B
Beta
0.65
Industry
Drug Manufacturers - Specialty & Generic

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
3
P/E 2025E
17.30x
P/Revenue 2025E
3.45x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
42.30%
Net Profit Margin 2025E
19.97%
ROE 2025E
12.47%
ROCE 2024
13.44%

Dividends

DPS 2025E
CN¥0.02
Payout Ratio 2025E
3.57%
Div. Yield 2025E
0.21%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

gainify
603707 logo

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

603707

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, ...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Yongqun, Tang

Employees

1,360

IPO Date

2017-07-19

Headquarters

No.16 Xuefu Road,High&New Tech Development Zone, Nanjing, Jiangsu Province, 210061, China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.